← All companies
BridgeBio Pharma, Inc.
BBIO - Company ID 0001743881
Market cap$14.66 B
Rank#758
Filings770
Market capitalization of BridgeBio Pharma, Inc.
As of 2026-09-07, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $14.66 B, making it the #758 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-09-07 | $14.66 B |
| 2026-09-06 | $14.66 B |
| 2026-09-05 | $14.66 B |
| 2026-09-04 | $14.53 B |
| 2026-09-03 | $14.77 B |
| 2026-09-02 | $15.02 B |
| 2026-09-01 | $15.00 B |
| 2026-08-31 | $14.91 B |
| 2026-08-30 | $15.00 B |
| 2026-08-29 | $15.00 B |
| 2026-08-28 | $15.07 B |
| 2026-08-27 | $15.41 B |
Market Cap of similar companies
Frequently asked questions
What is BridgeBio Pharma, Inc.'s market cap?
As of 2026-09-07, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $14.66 B, making it the #758 most valuable US-listed company.
Where does BridgeBio Pharma, Inc. rank by market cap?
BridgeBio Pharma, Inc. is the #758 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.